Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Combined Photosensitization and Vaccination Enable CD8 T-Cell Immunity and Tumor Suppression Independent of CD4 T-Cell Help.

Varypataki EM, Hasler F, Waeckerle-Men Y, Vogel-Kindgen S, Høgset A, Kündig TM, Gander B, Halin C, Johansen P.

Front Immunol. 2019 Jul 5;10:1548. doi: 10.3389/fimmu.2019.01548. eCollection 2019.

2.

Comment on "An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness".

Penno CA, Wack N, Laguerre C, Hasler F, Numao S, Röhn TA.

Sci Transl Med. 2019 Jun 19;11(497). pii: eaav4538. doi: 10.1126/scitranslmed.aav4538.

PMID:
31217337
3.

Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.

Numao S, Hasler F, Laguerre C, Srinivas H, Wack N, Jäger P, Schmid A, Osmont A, Röthlisberger P, Houguenade J, Bergsdorf C, Dawson J, Carte N, Hofmann A, Markert C, Hardaker L, Billich A, Wolf RM, Penno CA, Bollbuck B, Miltz W, Röhn TA.

Sci Rep. 2017 Oct 19;7(1):13591. doi: 10.1038/s41598-017-13490-1.

4.

Amyloid-like aggregation of provasopressin in diabetes insipidus and secretory granule sorting.

Beuret N, Hasler F, Prescianotto-Baschong C, Birk J, Rutishauser J, Spiess M.

BMC Biol. 2017 Jan 26;15(1):5. doi: 10.1186/s12915-017-0347-9.

5.

Methodological Problems on the Way to Integrative Human Neuroscience.

Kotchoubey B, Tretter F, Braun HA, Buchheim T, Draguhn A, Fuchs T, Hasler F, Hastedt H, Hinterberger T, Northoff G, Rentschler I, Schleim S, Sellmaier S, Tebartz Van Elst L, Tschacher W.

Front Integr Neurosci. 2016 Nov 29;10:41. eCollection 2016. Review.

6.

The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists.

Boehncke WH, Anliker MD, Conrad C, Dudler J, Hasler F, Hasler P, Häusermann P, Kyburz D, Laffitte E, Michel BA, Möller B, Navarini AA, Villiger PM, Yawalkar N, Gabay C.

Dermatology. 2015;230(1):75-81. doi: 10.1159/000367688. Epub 2015 Jan 6.

7.

Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.

Quednow BB, Treyer V, Hasler F, Dörig N, Wyss MT, Burger C, Rentsch KM, Westera G, Schubiger PA, Buck A, Vollenweider FX.

Neuroimage. 2012 Feb 15;59(4):3922-32. doi: 10.1016/j.neuroimage.2011.09.045. Epub 2011 Oct 5.

PMID:
21996132
8.

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.

Studerus E, Kometer M, Hasler F, Vollenweider FX.

J Psychopharmacol. 2011 Nov;25(11):1434-52. doi: 10.1177/0269881110382466. Epub 2010 Sep 20.

PMID:
20855349
9.

GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.

Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX, Ametamey SM, Westera G.

Appl Radiat Isot. 2009 Apr;67(4):598-601. doi: 10.1016/j.apradiso.2008.12.007. Epub 2008 Dec 24.

10.

C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays.

Spohn P, Hirsch C, Hasler F, Bruinink A, Krug HF, Wick P.

Environ Pollut. 2009 Apr;157(4):1134-9. doi: 10.1016/j.envpol.2008.08.013. Epub 2008 Sep 27.

PMID:
18824284
11.

Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA.

Hasler F, Studerus E, Lindner K, Ludewig S, Vollenweider FX.

J Psychopharmacol. 2009 Nov;23(8):923-35. doi: 10.1177/0269881108094650. Epub 2008 Jul 17.

PMID:
18635693
12.

Effects of varied doses of psilocybin on time interval reproduction in human subjects.

Wackermann J, Wittmann M, Hasler F, Vollenweider FX.

Neurosci Lett. 2008 Apr 11;435(1):51-5. doi: 10.1016/j.neulet.2008.02.006. Epub 2008 Feb 9.

PMID:
18325673
13.

Diagnosis of rheumatoid arthritis: multivariate analysis of biomarkers.

Wild N, Karl J, Grunert VP, Schmitt RI, Garczarek U, Krause F, Hasler F, van Riel PL, Bayer PM, Thun M, Mattey DL, Sharif M, Zolg W.

Biomarkers. 2008 Feb;13(1):88-105. doi: 10.1080/13547500701669410 .

PMID:
18188726
14.

Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.

Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX.

Psychopharmacology (Berl). 2007 Dec;195(3):415-24. Epub 2007 Sep 14.

15.

Effects of psilocybin on time perception and temporal control of behaviour in humans.

Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX.

J Psychopharmacol. 2007 Jan;21(1):50-64. Epub 2006 May 19.

PMID:
16714323
16.

Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.

Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX.

J Cogn Neurosci. 2005 Oct;17(10):1497-508.

17.

Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.

Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX.

Neuropsychopharmacology. 2005 Jun;30(6):1154-62.

18.

Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.

Liao H, Wu J, Kuhn E, Chin W, Chang B, Jones MD, O'Neil S, Clauser KR, Karl J, Hasler F, Roubenoff R, Zolg W, Guild BC.

Arthritis Rheum. 2004 Dec;50(12):3792-803.

19.

[Why do schizophrenic patients smoke?].

Cattapan-Ludewig K, Ludewig S, Jaquenoud Sirot E, Etzensberger M, Hasler F.

Nervenarzt. 2005 Mar;76(3):287-94. Review. German.

PMID:
15448920
20.

Psilocybin impairs high-level but not low-level motion perception.

Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX.

Neuroreport. 2004 Aug 26;15(12):1947-51.

PMID:
15305143
21.

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.

Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX.

Psychopharmacology (Berl). 2004 Mar;172(2):145-56. Epub 2003 Nov 13.

PMID:
14615876
22.

Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.

Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, Kneer J, van der Auwera P, Stevens RM; Rheumatology Group 791.

J Rheumatol. 2003 Apr;30(4):680-90.

PMID:
12672184
23.

Acetylcodeine as a urinary marker to differentiate the use of street heroin and pharmaceutical heroin.

Brenneisen R, Hasler F, Würsch D.

J Anal Toxicol. 2002 Nov-Dec;26(8):561-6.

PMID:
12501913
24.

Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.

Hasler F, Bourquin D, Brenneisen R, Vollenweider FX.

J Pharm Biomed Anal. 2002 Sep 5;30(2):331-9.

PMID:
12191719
25.
26.

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.

Hasler F, Bourquin D, Brenneisen R, Bär T, Vollenweider FX.

Pharm Acta Helv. 1997 Jun;72(3):175-84.

PMID:
9204776
27.

Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans.

Krähenbühl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R.

J Clin Endocrinol Metab. 1994 Mar;78(3):581-5.

PMID:
8126129
28.

Analysis and pharmacokinetics of glycyrrhizic acid and glycyrrhetinic acid in humans and experimental animals.

Krähenbühl S, Hasler F, Krapf R.

Steroids. 1994 Feb;59(2):121-6. Review.

PMID:
8191540
29.
30.

Soluble tumor necrosis factor receptors in human inflammatory synovial fluids.

Roux-Lombard P, Punzi L, Hasler F, Bas S, Todesco S, Gallati H, Guerne PA, Dayer JM.

Arthritis Rheum. 1993 Apr;36(4):485-9.

PMID:
8384452
31.

[If I had chronic polyarthritis--current ideas on basic therapy].

Hasler F.

Schweiz Rundsch Med Prax. 1993 Mar 23;82(12):349-52. German.

PMID:
8465132
32.

Diffuse idiopathic skeletal hyperostosis (DISH) of the elbow: a cause of elbow pain? A controlled study.

Beyeler C, Schlapbach P, Gerber NJ, Fahrer H, Hasler F, van der Linden SM, Bürgi U, Fuchs WA, Ehrengruber H.

Br J Rheumatol. 1992 May;31(5):319-23.

PMID:
1581773
33.

Immunoreactive circulating alpha-interferon in rheumatoid arthritis.

Hasler F.

Br J Rheumatol. 1990 Aug;29(4):315-6. No abstract available.

PMID:
2379052
34.

[Rheumatologic causes of brachialgia and their treatment].

Hasler F, Bona E.

Ther Umsch. 1988 Nov;45(11):780-6. German. No abstract available.

PMID:
3265224
35.
36.

[Management strategy of chronic polyarthritis].

Hasler F, Gerber NJ.

Ther Umsch. 1985 Oct;42(10):666-70. Review. German. No abstract available.

PMID:
3909485
37.

[Principles and value of serologic studies in rheumatism].

Hasler F, Gerber HA, Wälti ER, Hess MW.

Ther Umsch. 1985 Oct;42(10):663-5. Review. German. No abstract available.

PMID:
3909484
38.

[Bacterial arthritis: diagnosis and treatment].

Hasler F, Gerber AU.

Ther Umsch. 1985 Oct;42(10):659-62. Review. German. No abstract available.

PMID:
3909483
39.

[Recent aspects of Epstein-Barr virus infections].

Hasler F.

Schweiz Med Wochenschr. 1984 Apr 14;114(15):520-3. German.

PMID:
6328644
40.

Epstein-Barr virus and rheumatoid arthritis.

Bluestein HG, Hasler F.

Surv Immunol Res. 1984;3(1):70-7. No abstract available.

PMID:
6326237
41.

Vasculitis: immunological aspects.

Hasler F.

Eur Neurol. 1984;23(6):389-93.

PMID:
6150851
45.
47.

[Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].

Stojan B, Hasler F.

Wien Klin Wochenschr. 1977 Nov 11;89(21):713-6. German.

PMID:
919557
48.

[Laboratory findings in patients with rheumatoid arthritis during D-penicillamine- and goldtherapy (author's transl)].

Stojan B, Hasler F.

Schweiz Rundsch Med Prax. 1977 Nov 8;66(45):1435-6. German. No abstract available.

PMID:
928308
49.

[Two-phase course of IgM and rheumatoid factors during D-penicillamine therapy].

Stojan B, Hasler F.

Z Rheumatol. 1977 May-Jun;36(5-6):194-9. German.

PMID:
302538
50.

Supplemental Content

Loading ...
Support Center